Search page

A dose ranging study of sting challenge and specific lgE, IgG4, venom skin test and basophil activation responses to ant venom immunotherapy with and without delta-inulin adjuvant

AI as a game-changer: predicting biomarkers to transform allergy immunotherapy

Absence of alpha-tryptase isoforms is associated with less severe adverse events during peanut-oral immunotherapy

Absence of early exposure to dietary antigens impairs the host capacity to establish oral tolerance to food proteins

Achieving Remission with Peanut Sublingual Immunotherapy

Active immunotherapy with recombinant Bet v 1

Adherence to venom immunotherapy : a french monocentric retrospective study

Adult-onset food protein-induced enterocolitis syndrome. Cytokine variations after positive oral food challenges

Advances in Allergen Immunotherapy

Advances in Allergen Immunotherapy (AIT)

Advances in Immunotherapy

Advances in epicutaneous immunotherapy for the management of patients with food allergy

Allergen Immunotherapy

Allergen Immunotherapy Improves Bronchial Epithelial Tolerance and Antiviral Responses in Patients with House Dust Mite Allergic Asthma

Allergen Immunotherapy decreases biologicals use in allergic rhinitis with chronic rhinosinusitis with nasal polyps (CRSwNP)

Allergen Immunotherapy for the prevention of respiratory allergy

Allergen Immunotherapy in the Republic of Kazakhstan

Allergen immunotherapy

Allergen immunotherapy (AIT) in pregnancy, focus on the use of carbamylated monomeric allergoid

Allergen immunotherapy 01

Allergen immunotherapy 02

Allergen immunotherapy 03

Allergen immunotherapy 04

Allergen immunotherapy 05

Allergen immunotherapy 1

Allergen immunotherapy 2

Allergen immunotherapy 3

Allergen immunotherapy 4

Allergen immunotherapy 5

Allergen immunotherapy 6

Allergen immunotherapy 7

Allergen immunotherapy and Anaphylaxis

Allergen immunotherapy and biologicals: when and how

Allergen immunotherapy for airway allergy

Allergen immunotherapy for allergic disease: Indications and contraindications

Allergen immunotherapy in childhood: setting up the therapeutic goals

Allergen immunotherapy in clinical studies

Allergen immunotherapy in food allergy, what’s new?

Allergen immunotherapy in patients with allergic rhinitis and asthma associated with reduced risk of severe COVID-19

Allergen immunotherapy – Basic and clinical perspective

Allergen metabolism by human oral bacteria alters its allergenicity

Allergen-specific IgE-blocking antibodies in the course of allergen immunotherapy

Allergen-specific IgE/IgG4 ratio as biomarker of allergen immunotherapy efficacy in house dust mite-sensitized allergic rhinitis

Allergen-specific immunotherapy based on purified and modified Fel d 1 allergen from cat dander

Allergic, but still want them: A Mix Pet Dander Immunotherapy

AllergoOncology: Application of the basophil activation test (BAT) in pre-clinical testing and the first-in-class clinical trial of anti-cancer IgE immunotherapy

AllergoOncology: The role of BAT in pre-clinical and clinical assessments of potential hypersensitivity to anti-cancer IgE immunotherapy

Allergy Therapeutics – Setting a new standard for grass subcutaneous immunotherapy

Alterations in B cell memory induced by house dust mite allergen immunotherapy

An interim analysis of a multi-center, oPEn label, Randomized study to investigate the saFEty of an optimal acCelerated scheme for immunoTherapy in adolescent and adult patients with moderate to severe AR with or without asthma in China. (PERFECT)

Analysis of DNA repair capacity of peripheral blood lymphocytes from asthmatic patients treated with oral corticosteroids

Analysis of immunological and cellular tolerance biomarkers during bee venom immunotherapy

Analyzing Factors Influencing Adherence to Classify Adherence Levels in Patients Treated with Allergen Immunotherapy

Anaphylaxis to Beta-Lactams: The Importance of the Oral Challenge Test in Diagnosis

Anaphylaxis with omeprazole presenting positive oral challenge to esomeprazole

Antigen-specific IgE antibody levels as negative predictors of oral food challenge with cow’s milk in children with cow’s milk allergy

Application Study on the prevention and treatment of spleen aminopeptide oral solution on seasonal allergic rhinitis

Application of allergen standardization in allergen-specific immunotherapy (AIT)

Are LADDERS the new Oral Food Challenge?

Are oral food challenges still necessary for diagnosing food allergy

Artificial intelligence and precision immunology: pioneering biomarker discovery in allergen immunotherapy

Artificial intelligence-based B-cell epitope peptide immunotherapy alleviates chitin-binding protein-induced type 2 airway inflammation in Blomia tropicalis

Assessing protocol variability for FPIES oral food challenges

Assessing the role of specific IgA in prophylactic sublingual immunotherapy for peanut allergy: A Brown Norway rat study

Assessment of the Efficacy of Specific Immunotherapy After a Long Break in Asthmatic Patients

Asthma phenotype markers did not affect allergen immunotherapy effectiveness

BDNF as a biomarker for evaluating clinical response in allergic rhinitis patients undergoing allergen-specific immunotherapy

Basophil activation test as a predicting tool for effective Pru p 3 sublingual immunotherapy response in lipid transfer protein allergy

Best candidate for allergen-specific immunotherapy

Blocking antibodies from food immunotherapy unravelled at the molecular level

Boiled peanut or roasted peanut for oral immunotherapy: Results from the BOPI-2 Study

Build-Up of Wasp Venom Immunotherapy with Alutard-Depot SQ during Supply Shortage: A Retrospective Case Series

Bumblebee venom allergy as an emerging occupational allergy: safety and efficacy of bumblebee venom immunotherapy in a large single-center cohort

CHAPTER-3 Phase 3 Trial Design: Efficacy and Safety of the Oral Bradykinin B2 Receptor Antagonist Deucrictibant Extended-Release Tablet for Prophylaxis of Hereditary Angioedema Attacks

Carry-over effect of 300 IR house dust mite sublingual immunotherapy tablet and relationship with disease activity: a post hoc analysis

Challenges in food allergen immunotherapy

Changing Allergen Immunotherapy Practice Profiles in Mexico

Characterization of adaptative immune cells after double-blind placebo-controlled oral food challenges

Clinical Assessment of Specific Immunotherapy Efficacy in Individuals with House Dust Mite-Induced Allergic Rhinoconjunctivitis

Clinical Characteristics of Anaphylaxis Secondary to Subcutaneous Allergen-Specific Immunotherapy in a Pediatric Hospital in Mexico

Clinical Evaluation of subcutaneous immunotherapy (SCIT) containing a mixture of mites, in depot polymerized formulation without dilutional effect. Results from a prospective multicenter study

Clinical and immunological aspects in allergen immunotherapy

Clinical and immunological comparison between two subcutaneous immunotherapy products in children with allergic rhinitis

Clinical evaluation of an immunotherapy treatment with Vespa velutina venom in allergic patients. Results from a prospective multicenter Study: W-STING Study

Clinical outcomes used in allergen immunotherapy in allergic asthma in the era of Data Science

Clinical remission of allergic rhinoconjunctivitis with a 300IR 5-grass pollen sublingual immunotherapy tablet

Clinical studies on Allergen Immunotherapy with inhaled allergens: optimization and standardization of methodological approaches

Clinical studies on allergen immunotherapy with inhaled allergens: optimization and standardization of methodological approaches

Clonal mast cell disorders, allergy to hymenoptera venom and venom immunotherapy – our experience

Cluster immunotherapy for bee venom in delayed levo-tyrosine formulation with short protocol

Commercial product for oral food challenges: CON

Commercial product for oral food challenges: PRO

Comparison of basophil activation by different yellow jacket venoms from three continents and venom used in immunotherapy

Comparison of the efficacy of subcutaneous and sublingual immunotherapy for the treatment of allergic asthma in children

Consistent long term benefit of allergen immunotherapy in patients with allergic rhinitis

Coordinated specific IgG2 and IgE responses are associated with high clinical benefit of allergen immunotherapy with 300 IR house dust mite sublingual tablets in a large European cohort

Cow Milk Oral Immunotherapy: A Single-Center Experience

Cracking the Code: Immunological Changes Leading to Raw Egg Tolerance During Immunotherapy with Cooked Egg

Criteria used by health professionals on the selection of allergen immunotherapy in real clinical practice. CHOICE project results from Interim analysis 2023: PATIENT’S RESULTS

Criteria used by health professionals on the selection of allergen immunotherapy in real clinical practice. CHOICE project results from Interim analysis 2023: DOCTOR’S RESULTS

Cross-tolerance to cashew by prophylactic sublingual immunotherapy with different tree nuts in Brown Norway rats

Current knowledge on venom allergen immunotherapy

DBV Technologies – Epicutaneous route: an innovative potential approach to food immunotherapy

DRAGO Application: Implementing Adherence and to House Dust Mite Allergen Immunotherapy

Delving deeper in allergen immunotherapy

Demystifying the fear of lack of adherence to sublingual immunotherapy (SLIT)

Designing Modified Variants of Ara h 1 and Ara h 2 for Safe and Effective Immunotherapy

Development and implementation of an intelligence platform for management of allergen immunotherapy in China

Development of a thermosensitive poloxamer formulation designed to provide a controlled release of the active pharmaceutical ingredient in birch pollen allergen immunotherapy

Development of standardised challenge meals to meet regulators demands for Oral Food Challenges

Differential study of whole genome expression profiles of peripheral blood mononuclear cells in children with dust mite specific immunotherapy for asthma

Direct oral provocation in adults (without skin testing first)

Discovering new horizons in allergen immunotherapy

Do sIgE predict the oral food challenge outcomes in children with fish allergy?

Do we need commercial products for oral food challenges?

EFFECTIVENESS AND SAFETY OF SPECIFIC SUBLINGUAL IMMUNOTHERAPY WITH Pru p3 EXTRACT IN PATIENTS WITH LTP ALLERGY

EUROBAT ORAL ABSTRACT SESSION

Early Immunologic Parameters Predicting Response to Sublingual Immunotherapy in Allergic Rhinitis Patients

Early immunotherapy with aeroallergens and impact on future allergy

Early inflammatory reactions in mice after immunotherapy with an allergen microcrystalline tyrosine adsorbate

Effect of 300 IR house dust mite sublingual immunotherapy tablet in paediatric patients and relationship with disease activity

Effect of Metformin on allergen specific immunotherapy

Effect of allergen – specific immunotherapy on PFS symptoms

Effect of allergen immunotherapy on quality of life

Effect of allergen specific immunotherapy on PFS symptoms

Effect of non-specific Lipid Transfer Protein (nsLTP) allergies in oral and gut epithelial barrier integrity

Effect of sublingual immunotherapy on allergic rhinitis: Real-life data analysis

Effectiveness and Safety Study of Subcutaneous Immunotherapy for Respiratory Allergy to Dermatophagoides and Lepidoglyphus Destructor

Effectiveness and safety of Venom ImmunoTherapy (VIT) with “Rapid Cluster” induction protocol

Effectiveness of House Dust Mite Subcutaneous Immunotherapy on Co-existing Allergen Symptoms in Polysensitized Patients with Allergic Rhinitis: A Multicenter Retrospective Analysis

Effectiveness of sublingual immunotherapy in patients with atopic dermatitis allergic to house dust mite: an open label extension study

Effectivity and serological correlation analysis in patients undergoing their first year of mixed subcutaneous immunotherapy for dust mites and cat

Efficacy Study on Intratonsillar Immunotherapy for Patients with Allergic Rhinitis Induced by House Dust Mites (Tonsil-AIT)

Efficacy and Safety of Hymenoptera Venom Immunotherapy

Efficacy and Safety of Oral Deucrictibant, a Potent Bradykinin B2 Receptor Antagonist, in Prophylaxis of Hereditary Angioedema Attacks: Results of CHAPTER-1 Phase 2 Trial

Efficacy and Safety of the Oral Bradykinin B2 Receptor Antagonist Deucrictibant Immediate-Release Capsule in Treatment of Hereditary Angioedema Attacks: RAPIDe-3 Phase 3 Trial Design

Efficacy and safety of HDM-specific subcutaneous immunotherapy on atopic dermatitis

Efficacy and safety of allergen immunotherapy in clinical practice

Efficacy and safety of sublingual immunotherapy for mite in children and adolescents with AR

Efficacy and safety profile of immunotherapy for multiple allergens in polysensitized patients with allergic rhinitis: a systematic review and meta-analysis

Efficacy of House Dust Mite Immunotherapy in Chinese Allergic Rhinitis Patients with Diverse Sensitization Patterns: A Multicenter Study

Efficacy of two years of treatment with anti-IL-5/R therapy for reduction in use of oral glucocorticoids in patients with eosinophilic granulomatosis with polyangiitis

Efficacy of virus-like particle (VLP)-based immunotherapy in a mouse model of HDM allergy

Epicutaneous Allergen Administration with Microneedles as a Novel Method of Immunotherapy for House Dust Mite (HDM) Allergic Rhinitis

Epicutaneous Immunotherapy : from mechanism to efficacy

Epicutaneous Immunotherapy with Peanut Allergy

Epicutaneous food allergen immunotherapy

Epitope Analysis and Mutation Design in Jug r 1 for Hypoallergenic Walnut Immunotherapy

Evaluation of Direct Oral Provocation Test Results in Mild Cutaneous Reactions to Cephalosporins in Children

Evaluation of Sublingual Immunotherapy for Cat Allergy: Results from a Non-Interventional Study

Evaluation of auditory function in children with allergic rhinitis treated with specific immunotherapy

Evaluation of sustained unresponsiveness in children with IgE-Mediated Allergy to Cow’s Milk Proteins Trough Oral Tolerance Induction Protocols

Evaluation of the Oral Food Challenge Test Using Baked Milk and Baked Egg in Children with Allergies to Small Amounts of Cow’s Milk or Cooked Hen’s Egg

Evaluation of the Safety of Mixed Tree Nut Oral Food Challenges in the Management of Tree Nut Allergy

Evaluation of the efficacy, adverse effects, and cost-effectiveness of sublingual immunotherapy with dominant allergens for allergic rhinitis due to respiratory allergens in adults and children

Evaluation of the tolerability of the administration of subcutaneous immunotherapy in a cluster schedule, in patients with rhinoconjunctivitis and/or asthma with sensitization to Olea europaea with or without sensitization to grasses

Evaluation of total Immunoglobulin D in sublingual immunotherapy for allergic rhinitis

Evolution of atopic keratoconjunctivitis in patients with severe to moderate atopic dermatitis treated with oral Janus kinase inhibitors

Exacerbation of eosinophilic esophagitis in a child with seasonal allergic rhinitis during sublingual immunotherapy

Expansion of allergen-specific type 2 memory B cells with an altered phenotype after immunotherapy for bee venom or ryegrass pollen allergy

Experience with ALUTARD SQ Immunotherapy in Patients Allergic to Hymenoptera Venom

Exploring the Protective Potential: Subcutaneous Immunotherapy associated with C. acnes as a reductor of COVID-19 Severity in Older Patients – A Single-Center Observational Study

Factors affecting the outcome of Oral Food Challenges in children

Factors associated with higher serum IgG4 response in children treated with allergen immunotherapy

Factors associated with severity of reactions during oral food challenge test

Field Stings in Patients Undergoing Hymenoptera Venom Immunotherapy in a Healthcare Area of Central Spain

First clinical practice of using biologic therapy with dupilumab in combination with allergen-specific immunotherapy in a patient with severe atopic dermatitis and bronchial asthma

Flash talks on Allergen Immunotherapy 1

Flash talks on Allergen Immunotherapy 2

Flash talks on Allergen Immunotherapy 3

Flash talks on Allergen Immunotherapy 4

Food-allergen immunotherapy : how do I get started?

From allergen molecules to allergy management: can molecular diagnosis improve allergen immunotherapy efficacy?

Giving birth to a food allergen: from oral tolerance to the epithelial barrier dysfunction

Global Stage Session 3 – Successes and challenges of Immunotherapy

Graded oral challenge to delabel suspected non-steroidal anti-inflammatory drugs (NSAIDs) hypersensitivity in children

House dust mite sublingual immunotherapy comprehensively improves asthma and allergic rhinitis in children and adolescents

How allergists around the world perceive innovation in the context of allergen Immunotherapy AIT: an international survey

How effective and safe venom allergen immunotherapy is in children

Hymenoptera venom immunotherapy with 210 minutes Ultra-Rush protocol: patient profile and potential risk factors for systemic reactions

ILIT.NU: Intralymphatic immunotherapy and placebo affected cSMS similarly in grass pollen allergic individuals in a large clinical trial

ILIT.NU: Titration of Allergen for Treatment of Grass Pollen Induced Rhinoconjunctivitis with Intralymphatic Immunotherapy

Identification of the optimal immunotherapy via CAP Inhibition in Vespa velutina anaphylaxis patients

IgG-Epitope Mapping of Birch-Pollen Bet v 1 Allergen in Allergic and Treated Patients for the Design of Hypoallergenic Immunotherapy Allergens

Immune mechanisms of food immunotherapy

Immunophenotypes of Food Allergy and Responses to Immunotherapy Across the Life Course

Immunotherapy for LTP allergy

Immunotherapy for food allergy. What’s new?

Immunotherapy from patient and epidemiological study perspective

Immunotherapy in Food allergies : New frontiers

Immunotherapy in childhoood asthma: is it worth it?

Immunotherapy in food allergy

Immunotherapy in the clinic

Immunotherapy with Vespa velutina nigrithorax venom: safety of ultra-rush protocol and preliminary clinical results

Impact of Security Measures Implementation in Subcutaneous Allergen Immunotherapy Administration at a Pediatric Hospital in Mexico

Impact of a 3-tree sublingual immunotherapy liquid formulation in birch family pollen-allergic patients on prevention of disease progression and/or asthma onset

Impact of allergic rhinitis activity on the effect of 300IR house dust mite sublingual immunotherapy tablet in adolescent patients

Impact of different prophylactic sublingual immunotherapy regimes on peanut allergy prevention in Brown Norway rats

Impact of liquid sublingual immunotherapy on asthma worsening prevention: GINA treatment stepping up results from the real-world EfficAPSI study

Impact of liquid sublingual immunotherapy with mixed pollen allergens on asthma prevention in polyallergic patients: results from the real-world EfficAPSI study

Increased Inhibitory Surface Marker PD-1 Expression in CD4+T Cells and Th2+T Cells in Allergen-specific Immunotherapy

Increased the serum Blomia tropicalis antibody levels in children with Dermatophagoides pteronyssinus immunotherapy

Indefinite immunotherapy with different extracts in systemic mastocytosis

Individual Differences in Response to Dust-Mite-Allergen Specific Immunotherapy in Allergic Rhinitis: A Meta-analysis of Randomized Controlled Trials

Induction of oral specific tolerance to cow´s milk proteins before 12 months of age – is it worth it?

Innovations in Food Allergy Immunotherapy

Interim safety review of PVX108 peptide immunotherapy in an ongoing Phase 2 trial in peanut-allergic adolescents and children

Intestinal-restricted location of allergen-specific regulatory T cells is driven by oral consumption of the allergen in murine models

Intralymphatic immunotherapy of allergic rhinoconjunctivitis with grass allergoid microcrystalline tyrosine adsorbate produced reduced medication use and symptoms: a double-blind placebo-controlled trial

Intralymphatic immunotherapy with aluminium hydroxide based grass allergen reduced medication use in patients with allergic rhinoconjunctivitis: a double-blind randomized placebo-controlled trial

Intravenous immunotherapy with Der p 1-containing nanoparticles alleviates allergic response in a murine model of allergic rhinitis

Is there still a role for oral corticosteroids in the management of CRS

Isolated Codeine Allergy with Evidence of Tolerance to Oral Morphine: A Case Report

Kinetics of IgG4 after Vespula venom immunotherapy administered with an ultra-rush protocol

Long-Term Prophylactic Treatment With Oral Deucrictibant Improves Disease Control and Health-Related Quality of Life in Participants With Hereditary Angioedema in the CHAPTER-1 Open-Label Extension Study

Long-Term Safety and Efficacy of Oral Deucrictibant for Prophylaxis in Hereditary Angioedema: Data Snapshot Results of the CHAPTER-1 Open-Label Extension Study

Long-Term Safety and Efficacy of Oral Deucrictibant for Treatment of Hereditary Angioedema Attacks: Results of the RAPIDe-2 Extension Study

Long-Term, Real-World Effectiveness of Allergen Immunotherapy in Reducing Infectious Events in Allergic Rhinitis Patients with and without Asthma

Long-term efficacy and re-sting outcomes following venom immunotherapy discontinuation: A 978-patient analysis

Management of fish allergy based on Oral Food Challenge

Mapping the Patient’s Journey Prior to Allergen Immunotherapy

Microneedles-based transdermal allergen specific immunotherapy protects against gliadin induced anaphylaxis in a mouse model

Minimum resources to run an immunotherapy clinic safely

Missense variant KIT p.D816V suggestive of mast cell disorder predisposes to Hymenoptera venom immunotherapy treatment complications and failure

Modulation of B cell memory responses by house dust mite allergen immunotherapy

Modulation of allergen-specific type 2 memory B cells over the course of 18 months sublingual immunotherapy for house dust mite allergy

Monitoring for early warning signs of asthma attacks and response to treatment with oral corticosteroids using the Albus Home contactless monitoring system

Monitoring response to immunotherapy

Mucosal delivery of allergen-specific immunotherapy with vaccine adjuvants suppresses allergic disease through both humoral and cellular immune mechanisms

Multiple food protein-induced enterocolitis syndrome in a child with 8 positives oral food challenges

Murine IgG1 corresponding to human IgG4 increased by subcutaneous immunotherapy suppressed activation of group 2 innate lymphoid cells

Murine IgG1 increased by subcutaneous immunotherapy suppressed development of allergic asthma

Nationwide pivotal registry study on house dust mite immunotherapy in allergic rhinitis patients with or without asthma in China (NAVIGATOR)

Navigating Oral Food and Drug Provocation Tests: Assessing Tolerance and Safety in Clinical Settings

New directions in immunotherapy and vaccinology

New insights on allergen immunotherapy

No more restrictive diets for LTP allergic patients. The importance of oral food challenge

Novel allergen immunotherapy strategies

Nut Allergy in the Spotlight: The Crucial Role of Oral Provocation Tests

Nut allergy: the importance of molecular diagnosis and oral food challenge testing

Nut immunotherapy – Is it ready for prime time?

Omalizumab for oral desensitization in children with cow’s milk allergy

One-strength dose escalation using a birch pollen allergoid for subcutaneous immunotherapy is safe and well-tolerated in children, adolescents and adults

Optimising oral food challenges in IgE mediated food allergy

Oral Abstract Session 1 – Contact Dermatitis/Drug Reactions

Oral Abstract Session 2 – Atopic Dermatitis

Oral Abstract Session 25

Oral Abstract Session 26

Oral Abstract Session 27

Oral Abstract Session 28

Oral Abstract Session 29

Oral Abstract Session 3 – Urticaria/Angioedema

Oral Abstract Session 30

Oral Abstract Session 31

Oral Abstract Session 32

Oral Abstract Session 33

Oral Abstract Session 34

Oral Administration of Ginsenoside F1 Attenuates Allergic Atopic Dermatitis by Modulating T cell Activation

Oral Challenge Tests in an Outpatient Clinic: Is It Safe?

Oral Food Challenge Approaches in Food Protein-Induced Enterocolitis Syndrome: A Systematic Review

Oral Food Challenges in Children’s Health Ireland

Oral Mite Anaphylaxis after eating homemade Pizza with contaminated wheat flour

Oral Sebetralstat for On-demand Treatment of Hereditary Angioedema: Phase 3 KONFIDENT Trial Results

Oral allergy syndrome as a marker of food allergy in a monocentric cohort of atopic patients with eosinophilic esophagitis

Oral and skin sensitisation to peanut induce distinct immune response profiles – identification of potential biomarkers of route of sensitisation?

Oral food Challenge in Adults

Oral food challenge materials and protocols

Oral food challenge outcomes in a pediatric allergy outpatient office of a tertiary hospital

Oral immunotherapya for food allergy

Oral intake of food allergens promotes intestinal compartmentalization of antigen-specific regulatory T cells in mice

Outcomes of Bee Re-sting After Cessation of Venom Immunotherapy

Ovalbumin-loaded nanoparticles for allergen specific immunotherapy

Passive immunotherapy with anti-Bet v 1 mAb

Patient preference: A multinational discrete-choice-experiment (DCE) in pollen allergen immunotherapy (AIT)

Patients undergoing immunotherapy with Alternaria alternata: prevalence of asthma and co-sensitization to other allergens

Peanut allergens differently adhere to oral epithelia

Pediatric patients undergoing immunotherapy with alternaria alternata: demographic and clinical characterization

Poloxamer formulation for allergen immunotherapy reduces systemic allergic reactions in a mouse model

Positive effect of a 300IR dosing pump-administered liquid sublingual immunotherapy on allergic disease evolution: Results from the observational, prospective, longitudinal PRACTIS study

Positive impact on quality of life with a depigmented-polymerized house dust mite extract immunotherapy

Positive outcome of the pivotal Phase III study with PQ Grass, a modified grass allergen subcutaneous immunotherapy (SCIT) product using MicroCrystalline Tyrosine and Monophosphoryl Lipid A as adjuvant system

Predicting clinical response to allergen-specific immunotherapy to D. pteronyssinus using serological pre-treatment parameters

Predicting the Efficacy of Allergen Immunotherapy in Asthma Based on Initial-Year Outcome: Insights from the Estimated Daily Symptom and Medication Score

Prescription rates and adherence to bee- and vespid- immunotherapy in Austria – a population-based study

Present and future of allergen immunotherapy

Profile of patients treated with the 300IR liquid sublingual immunotherapy for cat allergy and perception of treatment effect: Results from a French survey

Progress in understanding the mechanisms of airborne allergen immunotherapy

Prophylactic Treatment with Oral Deucrictibant Improves Health-Related Quality of Life of Patients with Hereditary Angioedema

Prospective, pilot, phase 1 study of iPUMP© in patients starting sublingual allergen immunotherapy (Staloral©)

Protocol for a randomized, 5-arm study to evaluate the combination of omalizumab and allergen immunotherapy in patients with asthma due to house dust mites

Protocols and outcomes in FPIES oral food challenges

Protocols for venom immunotherapy in the era of depot formulations

Randomized Controlled Trial of Sublingual Immunotherapy for Egg Allergy

Reactions Due to Accidental Peanut Consumption During Epicutaneous Immunotherapy for Peanut Allergy in Toddlers

Reactivity, severity and tolerance development in 50 wheat-allergic children across two oral food challenges

Real-World Protective Effects of Epicutaneous Immunotherapy in Peanut-allergic Toddlers

Real-life Non-interventional Post authorization Safety Study with the SQ tree sublingual immunotherapy tablet

Real-life experience of allergen-specific immunotherapy

Real-world allergen immunotherapy effectiveness in allergic asthma

Real-world change in asthma symptom control and oral corticosteroid use in patients with severe asthma treated with mepolizumab stratified by atopic status: Post hoc analysis of REALITI-A at 2 years

Reduction in Oral Corticosteroid Burden in Patients With Moderate-to-Severe Asthma Initiating Dupilumab in the Real-World: The RAPID Registry

Retrospective evaluation of the outcome of 106 oral food challenges performed in 2017 to 2024

Risk Factors for Anaphylaxis in Food-Allergic Children During Oral Food Challenge Tests

Risk Factors for Early Adverse Events of Sublingual Immunotherapy for Allergic Rhinitis and their Impact on Short-term Treatment Outcomes

Role of sublingual immunotherapy in management of patients with moderate to severe allergic rhinitis; one year study

SEP-631: A Novel Selective and Potent Oral MRGPRX2 Inhibitor for the Treatment of Chronic Spontaneous Urticaria

SQ house dust mite (HDM) sublingual immunotherapy (SLIT)-tablet is well-tolerated in children with inadequately controlled HDM allergic asthma

Safety Data for House Dust Mite and Pollen Subcutaneous Allergen Immunotherapy in Children: Systemic Reactions and Risk Factors

Safety Profile and Clinical Outcome of Sublingual Immunotherapy (SLIT) with Pru p 3 in Patients with LTP Allergy Undergoing Food Reintroduction

Safety and Efficacy of Oral Deucrictibant for Treatment of Upper Airway and Laryngeal Hereditary Angioedema Attacks: Results from the RAPIDe-2 Extension Study

Safety and Tolerability of Rush Updosing Using a Mugwort Allergoid Extract for Subcutaneous Allergen Immunotherapy

Safety and compliance of sublingual immunotherapy with house dust mite extract in patients with atopic dermatitis for 1 year

Safety and efficacy of a 7-week immunotherapy protocol with aluminum hydroxide adsorbed bee venom

Safety and tolerability of in-season initiation of subcutaneous and sublingual allergen immunotherapy with SQ grass pollen products: a comprehensive review

Safety and tolerance response of a two day rush protocol treatment in immunotherapy using purified Apis mellifera dry Honeybee venom extract

Safety of Hymenoptera Venom Immunotherapy in Patients with Oncological and Autoimmune Diseases: A Clinical Case Series

Safety of a cluster strategy, effectiveness and immunological changes in allergic children sensitized to house dust mites with native and modified subcutaneous immunotherapy treatment

Safety of subcutaneous immunotherapy with mixtures of two allergens at maximum concentration: 10 year real-world data

Safety of ultra-rush immunotherapy starting protocol with the molecular extract Diater Alt a 1 mol mix

Safety profile in clinical trials of sublingual immunotherapy with carbamylated monomeric allergoid

Sebetralstat as Oral On-demand Treatment for Hereditary Angioedema: Interim Analysis of Demographics and Attack Characteristics from the Open-label KONFIDENT-S Trial

Selecting the right immunotherapy for Vespa velutina nigrithorax anaphylaxis: does one treatment fits all?

Short-term benefits of sublingual immunotherapy in routine clinical practice: Patient Benefit Index by class in the observational, prospective, longitudinal study PRACTIS

Short-term benefits of sublingual immunotherapy in routine clinical practice: deciphering factors influencing the patient satisfaction in the observational, prospective, longitudinal study PRACTIS

Should we be concerned when starting allergen immunotherapy in patients with controlled HIV infection or autoimmune diseases?

Specific IgE and IgG4 changes in adults undergoing peanut immunotherapy combined with omalizumab

Staggered oral peanut challenge with regular consumption at home

Stallergenes Greer – “Allergen Harmony”: New data for a tailored and sustained food and respiratory immunotherapy effect

Steroid sparing effect of 300IR house dust mite sublingual immunotherapy tablet in mite allergic rhinitis patients with concomitant asthma

Study design for A multicenter, open label, randomized Study to inveStigate the effIcacy of Subcutaneous immunoTherapy combined with vitamin D3 in children and adolescent patients with allergic rhinitis (ASSIST study)

Study design for efficacy evaluation of subcutaneOus immunotherApy in patients with obstructive Sleep apnea concomitant with allergIc rhinitiS (OASIS study)

Study design for the saFety assessment of an Accelerated up-dosing scheme using one Strength of a native house dust mite allergen extract for subcutaneous immunoTherapy in children with allergic asthma in China (FAST II study)

Study of Efficacy of Rush Sub Lingual Immunotherapy (RSLIT) in Cases of Severe Persistent Allergic Rhinitis

Subcutaneous Allergen-specific Immunotherapy in Pediatric Age – a level II hospital experience

Subcutaneous immunotherapy with a depigmented cat allergoid in patients with cat allergy is safe and results primarily in delayed local reactions

Subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids is safe in a pre/co-seasonal treatment regimen – a subgroup comparison

Sublingual allergen immunotherapy in children with AR

Sublingual dust mite allergen immunotherapy reduces respiratory infections in children with allergic rhinitis

Sublingual immunotherapy for house dust mite allergy induces expansions of allergen-specific memory B cells expressing CD29 and downregulating IL4Rα

Sublingual immunotherapy with Pru p 3 induces DNA methylation changes towards tolerance in dendritic cells from patients with nsLTP allergy

Sublingual immunotherapy with peanut protein extract has an effect in Brown Norway rats sensitised via the skin

Successes and challenges of Immunotherapy

Successes and challenges of Immunotherapy in Poland and EU

Successful immunotherapy with cow’s milk and omalizumab in a 24-year-old patient with extreme cow’s milk allergy

Surfactants in oral care products may exacerbate Eosinophilic Esophagitis by disrupting epithelial barriers and triggering pro-inflammatory responses

Sustained and Long-term effect of allergen immunotherapy in local respiratory allergy

Sympout study: Evolution of clinical parameters in a pediatric population allergic to pollens or house dust mites treated with sublingual immunotherapy in liquid formulation standardized in TBU/ml

Sympout study: Need of medication for symptom control in patients with rhinitis and/or bronchial asthma due to house dust mites or pollens in treatment with sublingual immunotherapy in a standardized liquid formulation in TBU/ml

Systematic literature review and adjusted indirect treatment comparisons of 2 allergen immunotherapy treatments for grass pollen–induced allergic rhinitis

Systemic allergic reactions to subcutaneous allergen immunotherapy – A single center experience

Systemic reactions to subcutaneous immunotherapy in children

TAPAS – a long-term non-interventional study evaluating MCT (MicroCrystalline Tyrosine)-associated allergoids shows non-inferiority of clinical effectiveness in children compared to adults during a 3-year course of allergen immunotherapy

The Bacterial Lysate 0M-85BV reduces risk for exacerbations and oral corticosteroids in allergic asthma: A retrospective parallel group-controlled study

The Efficacy and Safety of Stepwise Oral Food Challenge in Children with Hen’s Egg Allergy

The Efficacy of Sublingual Immunotherapy in Mild versus Moderate Atopic Dermatitis Among Children with House Dust Mite Allergic Rhinitis

The Quest for Tolerance in Allergen Immunotherapy

The Role of Oral Food Challenges in Clinical Trials: Necessity or Redundancy?

The Sting Challenge Test: a key tool for monitoring the effectiveness of venom immunotherapy

The Utility of Predicting Outcomes by Considering Intake Amount and Antigen-Specific IgE Levels in Oral Food Challenge Tests

The effect of the sphenopalatine ganglion acupuncture on the clinical efficacy of cluster immunotherapy in patients with allergic rhinitis

The efficacy analysis and immunological changes after Alternaria alternata immunotherapy

The epicutaneous immunotherapy for peanut allergy: most recent results and perspectives

The individual benefit of subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids is already evident in the first season immediately after treatment

The journey to registration: challenges for allergen immunotherapy trials

The role of Innate Lymphoid Cells in food allergy and oral tolerance

The role of skin testing, serum IgE, and extended oral challenges in diagnosing childhood beta-lactam allergy: The CHildren Antibiotic Delabeling (CHAD) study

The safety of an optimal accelerated immunotherapy for allergic rhinitis in adolescent and adult patients in China (PERFECT study)

The successful switch of Hymenoptera venom immunotherapy (VIT) to a different manufacturer

The utility of basophil activation testing in honey bee venom allergy diagnosis and venom immunotherapy

Thresholds for microbiome-dependent oral tolerance

Trained innate immunity and immunotherapy

Treatment of HAE Attacks with Anticipated Future Oral On-demand Therapies as Reported by Patients

Treatment satisfaction and health literacy among patients undergoing allergen-specific immunotherapy -Data from a tertiary allergy centre

Tumor Necrosis Factor Receptor 2 (TNFR2) is crucial for the efficacy of Allergen-Specific Immunotherapy in a Pre-clinical Murine Model

Understanding of mechanisms of food immunotherapy

Understanding the Patient: Their Preferences for Venom Immunotherapy

Unmasking Mite Anaphylaxis – a Hidden Oral Allergen

Updates in the clinical management of allergen immunotherapy

Urinary PGDM is not elevated during oral food challenges for food protein-induced enterocolitis syndrome

Use of Dupilumab as Adjuvant Treatment in Oral Food Desensitization: A Case Report

Using the AllergyVax app to increase adherence to allergen subcutaneous immunotherapy

Utility of basophil activation test (BAT) in evaluation of efficacy of venom immunotherapy determined by sting challenge: A systematic review

Validation of a novel serum-based basophil activation test (iBAT) to evaluate efficacy of a pivotal Phase III PQ Grass immunotherapy trial

Venom Allergen Immunotherapy in Children: Efficacy, Persistence of Efficacy and Impact on Quality of Life

Venom Immunotherapy in children and adolescents: safety and outcome in a study group from a third level Italian center

Venom immunotherapy in children – do we have an age limit ? (case report)

Venom immunotherapy in mastocytosis

When Immunotherapy Strikes Twice: IgE Hypersensitivity and HES as Dual Adverse Effects of Pembrolizumab

Where are we currently in sublingual immunotherapy for food allergy?

Why So Sensitive? Identifying New Allergic Sensitization in Patients On Subcutaneous Immunotherapy (SCIT)

Аllergen-specific immunotherapy in patients with allergic rhinitis

Сytokine profile in patients with allergic rhinitis during allergen-specific immunotherapy with added vitamin D

Сytokine profiles in patients with allergic rhinitis during allergen-specific immunotherapy with and without added vitamin D

“Picking the Harmony”: The Science Behind Immunotherapy Treatments

“Rhythm of Success”: Sustaining Benefits in Allergen Immunotherapy

“Tuning In”: Patient Profiles Orchestrating Optimized Response to Immunotherapy

2-year outcome of low-dose oral immunotherapy for children with severe cashew allergy

Abatacept to induce remission of peanut allergy during oral immunotherapy (ATARI trial): baseline peanut-specific T cell responses of participants

Advances in Oral Immunotherapy

Allergen specific IgE is a stronger predictor of remission following Peanut Oral Immunotherapy in children aged 1-10 years

Analysis of epinephrine use during peanut (Arachis hypogaea) allergen powder-dnfp oral immunotherapy in individuals with peanut allergy aged 1 to 3 years

Antioxidant pine nut protein hydrolysate as a therapeutic oral immunotherapy agent in a murine model of pine nut allergy

Audit of Peanut Allergy Patients Eligible for Oral Immunotherapy (OIT) in a Paediatric Cohort at Galway University Hospital (2020-2023)

B Cell Repertoires and Phenotypes in Food Allergy and Oral Immunotherapy

Biologicals as adds on in oral immunotherapy for IgE mediated food allergy

Changes in IgG4 and IgE epitope binding profile are greater with sublingual than oral immunotherapy in milk-allergic children, and correspond to efficacy outcomes

Decreased frequency and severity of oral immunotherapy induced gastrointestinal eosinophilic reactions following revisions in treatment protocol

Descriptive Study on the Evolution of Patients Treated with Oral Immunotherapy (OIT) Using Pasteurized Egg White at the Fundación Alcorcón University Hospital

Descriptive study of the evolution of patients after oral immunotherapy with milk at the Hospital Universitario Fundación Alcorcón

Development of Eosinophilic Esophagitis in a Child with Multiple Food Allergies: The Role of Omalizumab, Oral Immunotherapy and Dietary Incompliance: A Case Report

Dietary outcomes following oral immunotherapy for cows milk allergy: Results from the SOCMA Study

Effectiveness of allergy immunotherapy on asthma medication use and asthma exacerbations: Results from the Real world Evidence of aLlergy immunotherapY (RELY) study

Effectiveness of allergy immunotherapy on symptom-relieving medication use: Results from the Real world Evidence of aLlergy immunotherapY (RELY) study

Evaluation of Patients with Venom Immunotherapy Indication When Immunotherapy Preparation Could Not Be Obtained

Evaluation of the IgEs amount and basophil activity changes during walnut oral immunotherapy

Evolution of pediatric patients with casein-specific IgE values>100 KU/L undergoing cow’s milk oral immunotherapy

Exposure-adjusted safety of peanut (Arachis hypogaea) allergen powder-dnfp oral immunotherapy in individuals with peanut allergy aged 1-3 years (POSEIDON trial)

FERMAH-OIT: Food Extensive Rapid Multi-Allergen Home Oral Immunotherapy; A novel OIT protocol without OmalizumabFERMAH-OIT: Food Extensive Rapid Multi-Allergen Home Oral Immunotherapy; A novel OIT protocol without Omalizumab

FRIENDLY TREE NUT AND SESAME ORAL IMMUNOTHERAPY PROTOCOTOLS (ALPEDIA-NOITs)

Fixed-Dose Oral Immunotherapy for High-Threshold Food Allergy: Efficacy and Safety in Real-World Practice

Flexible and Safe Oral Immunotherapy (OIT) Regimen Using Home Boiled Nut Broths (HBNB)

Food oral immunotherapy monitoring with OITcontrol® is related to reduced number of home adverse reactions and better treatment compliance compared with paper-based monitoring

Gut Microbial Bile and Amino Acid Metabolism Associate with Peanut Oral Immunotherapy Failure

High degree of desensitization after one year of early-life peanut oral immunotherapy – SmaChO Randomized Controlled Trial

IgE High-Affinity Receptor Expression as a Predictive Biomarker for Oral Immunotherapy Outcomes in Severe Egg and Milk Allergies

Immunologic profile and safety of milk oral immunotherapy in children with severe cow’s milk allergy – a series of cases

Impact of participant baseline factors on exposure-adjusted incidence of treatment-related adverse events during peanut oral immunotherapy

Incidence of patients who needed to change their allergy immunotherapy product specific to mites or pollens in Spanish allergy unitsIncidence of switching specific allergic immunotherapy products in Spanish allergy units

Increase in maximum tolerated dose and decrease in symptom severity during food challenge in a clinical trial of oral immunotherapy for peanut allergy in children aged 1 to 3 years

Is milk oral immunotherapy using a home up-dosing protocol a viable and safe treatment for the older milk allergic child?

Long-term Follow-up After Peanut Oral Immunotherapy During Preschool Years: Lessons from the IMPACT Trial

Low dose oral immunotherapy for children with severe cow’s milk allergy

Machine Learning-Based Prediction of Desensitization Success in Oral Immunotherapy for Hen’s Egg Allergy in Children

Management of Eosinophilic Esophagitis as a side effect of food oral immunotherapy

Molecular tools in support to walnut oral immunotherapy

NOVEL MULTI-NUTS ORAL IMMUNOTHERAPY PROTOCOLS (ALPEDIA-NOITs)

New mechanisms for the induction of tolerance by Oral Immunotherapy

One-year follow-up of children who achieved sustained unresponsiveness following early oral immunotherapy for various allergens

Oral Immunotherapy

Oral Immunotherapy for Adults with Food Allergies

Oral Immunotherapy for Fish Allergic Children

Oral Immunotherapy with omalizumab in an adult patient with severe milk and egg allergy

Oral immunotherapy (OIT) in walnut and hazelnut co-allergic patients: ELISA inhibition studies to direct treatment approach

Oral immunotherapy decreases expression of pro-inflammatory genes upon re-exposure to allergen in egg allergic children

Oral immunotherapy in cow’s milk allergic patients

Oral immunotherapy protocols for milk / egg

Oral immunotherapy to hazelnut in children: a single-center retrospective study in an Italian cohort

Outcomes of low-dose peanut food challenges in preschoolers when initiating peanut oral immunotherapy

Patterns of peanut ingestion in remission vs desensitized patients after completion of peanut oral immunotherapy at 3-years post-treatment

Peanut oral immunotherapy has not recuded basophil activation

Peanut oral immunotherapy in toddlers

Persisten severe cow’s milk allergy with successful oral immunotherapy in adulthood

Predicting treatment response to oral immunotherapy in peanut-allergic children using multi-omics risk scores

Predictors of response to oral immunotherapy

Prognostic value of specific IgE ratios in the tolerance of oral immunotherapy with egg allergy

Protein and allergen content variability of peanut-containing products used in oral immunotherapy for peanut allergy

ROCI-OIT: Rapid Oral Continuous Infusion – Oral Immunotherapy; A Breakthrough methodology in the science of OIT

Randomized controlled trial of pancake oral immunotherapy for egg allergy

Real-life experience with long-term oral immunotherapy for nut allergic children: A single center study from Luxembourg

Safety of oral immunotherapy in preschool aged children with single and multiple food allergy (the ORKA trial): a prospective intervention study

Slow oral immunotherapy for food allergy – what evidence do we have?

Small Doses, Big Benefits: The Promise of Low-Dose Oral Immunotherapy

Starting with Low-Dose Sesame Food Challenges for Oral Immunotherapy

The change in quality of life of adults with food allergy treated with oral immunotherapy

The overall diet and environmental factors in oral immunotherapy

Timing in oral immunotherapy : Early vs. Late introduction

Tolerance induction through oral immunotherapy

Two-year Outcomes of Low-dose Oral Immunotherapy for Children with Severe Walnut Allergy

5-year patient-reported outcomes after oral immunotherapy using heat-modified peanuts: results from the BOPI (Boiled Peanut Oral Immunotherapy) study

Basophil activation test as a marker of desensitization in Very Low-Dose Multi-Nut Immunotherapy and Very Low-Dose Peanut Oral Immunotherapy

High degree of sustained unresponsiveness and safety after three years of slow up-dose peanut oral immunotherapy in toddlers – results from the SmaChO study (Small Children Oral Immunotherapy)

Patient-reported outcomes after 5 years of oral immunotherapy for peanut allergy: results from the BOPI (Boiled Peanut Oral Immunotherapy) study

Welcome

Only match titles

What are you looking for?

Knowledge Hub

Website